The relationship between plasma concentration of paroxetine and CYP2D6 genotype in Japanese psychiatric patients

被引：0
|
作者：
Ueda, M [1 ]
Hirokane, G [1 ]
Morita, S [1 ]
Yokono, A [1 ]
Okawa, M [1 ]
Shimoda, K [1 ]
机构：
[1] Shiga Univ Med Sci, Otsu, Shiga 52021, Japan
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2002年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S223 / S223
页数：1
相关论文
共 50 条
  • [41] Dynamics and persistence of CYP2D6 inhibition by paroxetine
    Jurica, J.
    Zourkova, A.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2013, 38 (04) : 294 - 300
  • [42] The effect of CYP2C19 and CYP2D6 genotypes on the metabolism of clomipramine in Japanese psychiatric patients
    Yokono, A
    Morita, S
    Someya, T
    Hirokane, G
    Okawa, M
    Shimoda, K
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2001, 21 (06) : 549 - 555
  • [43] Impact of CYP2C19 and CYP2D6 genotypes on metabolism of amitriptyline in Japanese psychiatric patients
    Shimoda, K
    Someya, T
    Yokono, A
    Morita, S
    Hirokane, G
    Takahashi, S
    Okawa, M
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2002, 22 (04) : 371 - 378
  • [44] The effect of CYP2D6 and CYP2C19 genotypes on the metabolism of amitriptyline in Japanese psychiatric patients
    Hirokane, G
    Morita, S
    Yokono, A
    Someya, T
    Takahashi, S
    Okawa, M
    Shimoda, K
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2002, 17 : S7 - S8
  • [45] CYP2D6 GENOTYPE-DEPENDENT INTERACTION OF PAROXETINE AND CLARITHROMYCIN WITH THE INFERTILITY DRUG CLOMIPHENE
    Kerb, R.
    Ganchev, B.
    Boehmer, G. M.
    Igel, S.
    Sonnenberg, M.
    Schaeffeler, E.
    Schroth, W.
    Zanger, U.
    Brauch, H.
    Schwab, M.
    Muerdter, T. E.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S59 - S59
  • [46] CYP2D6 genotype and smoking influence fluvoxamine steady-state concentration in Japanese psychiatric patients: lessons for genotype-phenotype association study design in translational pharmacogenetics
    Suzuki, Yutaro
    Sugai, Takuro
    Fukui, Naoki
    Watanabe, Junzo
    Ono, Shin
    Inoue, Yoshimasa
    Ozdemir, Vural
    Someya, Toshiyuki
    JOURNAL OF PSYCHOPHARMACOLOGY, 2011, 25 (07) : 908 - 914
  • [47] Relationship between CYP2D6 genotype and haloperidol pharmacokinetics and extrapyramidal symptoms in healthy volunteers
    Gasso, Patricia
    Papagianni, Katerina
    Mas, Sergi
    Fernandez de Bobadilla, Ramon
    Albert Arnaiz, Joan
    Bernardo, Miquel
    Lafuente, Amalia
    PHARMACOGENOMICS, 2013, 14 (13) : 1551 - 1563
  • [48] RELATIONSHIP BETWEEN CYP2D6 GENOTYPE AND HALOPERIDOL PHARMACOKINETICS AND EXTRAPYRAMIDAL SYMPTOMS IN HEALTHY VOLUNTEERS
    Lafuente, A.
    Gasso, P.
    Papagianni, K.
    Mas, S.
    Fernandez de Bobadilla, R.
    Arnaiz, J. A.
    Bernardo, M.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 52 - 52
  • [49] CYP2D6 genotype and tamoxifen response
    James M Rae
    Matthew P Goetz
    Daniel F Hayes
    James N Ingle
    Lang Li
    Anna Maria Storniolo
    Vered Stearns
    David A Flockhart
    Breast Cancer Research, 7
  • [50] CYP2D6 phenotyping of psychiatric patients and healthy subjects
    Lohmann, P
    Bagli, M
    Mörlke, K
    Laux, G
    Kolbinger, M
    Rao, ML
    PSYCHOPHARMAKOTHERAPIE, 1999, 6 (02): : 64 - 66
12345